Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Rating Card

premiumPremium content

Unlock Expert's Rating and Top Picks Portfolio

Curated by Michael O'Reilly since 2020
1550+ opinions with 4.81 rating (one of the best performing expert)


Stock Opinions by Lorne Steinberg

COMMENT

Believes interest rates have most likely peaked. Retail sales data pointing towards consumer spending slowdown. Higher interest rates adding pressure on consumers. Expecting inflation to moderate with higher interest rates. Long term bond yields also impacting spending behavior. ~5.5% Canadian bank yields very attractive for investors. Lots of opportunity for investors in Canada at this moment. 

TOP PICK

Canadian banks very attractive. Currently trading at ~9x earnings. ~7% dividend yield is exceptional. Very strong wealth management business. Good for long term investors. Expecting double digit return going forward. 

TOP PICK

Consumer health spinoff from J&J. First rate consumer products business. Trading at discount to peers in sector. ~4% dividend attractive. Excellent array of brands in portfolio. Litigation always a concern, but overall not worried for the long term. 

TOP PICK

Top luxury brands business in Europe (Gucci etc.) New luxury fragrance acquisition very attractive. Trading at 15x earnings. Large margins on products very good for cash flow. Double digit revenue growth. ~3% dividend yield. Trading at discount to peers like LVMH. 

PAST TOP PICK
(A Top Pick Jul 22/22, Up 12%)

Has owned company for 15 years, and will keep position. Company has purchased ~50% of shares last 10 years. Ability to raise prices with inflation. Very attractive capital allocation skills. Consistently raised dividend. 

PAST TOP PICK
(A Top Pick Jul 22/22, Down 2%)

Very attractive business with excellent capital allocation skills. Share count keeps going down. Not worried about slowing economy with this business. Share price a good place to buy. Berkshire Hathaway a major shareholder. Recent earnings exceeded expectations. 

PAST TOP PICK
(A Top Pick Jul 22/22, Down 23%)

Very large acquisition in health clinics. Pharmacy side of business struggling. Becoming a major healthcare provider in USA. Trading at 8x earnings. Cash flow excellent. Good for long term investors. Will continue to hold. Strong management team. 

HOLD

Utility style company with reliable dividend. Lots of share issuance - a concern. Better options for investors in markets. Lots of a debt impacted by rising interest rates. 

HOLD

Utility style company with pipeline business. Believes dividend is safe. Lots of stock being issued for recent M&A. Not a growth company given nature of the business. Current dividend yield ~7% very attractive. 

WAIT

Spinoff from GE parent. Not buying shares at this time. Waiting to see how management performs. Strong sector (healthcare), but performance remains to be seen. 

RISKY

30 Year Treasuries: Risky government bond. Would prefer 1-5 year bonds. 

DON'T BUY

Rising interest rates have negative impact on business. Number of projects involved in, have had cost overruns. Would prefer Brookfield parent. 

DON'T BUY

Past 12 months has been tough on shareholders. Cost overruns and rising interest rates hard on bottom line. Not executing on business plan. Better options available for investors in the markets. 

PARTIAL BUY

Share price has under performed the past 10 years. 9% yield very attractive. Good for foreign income investors. Does not invest in sector due to growth prospects. 

BUY

Owns shares in company. Would recommend buying. Assets valuable since not building anymore. Strong pricing power. Free cash flow very strong. Excellent capital allocation with share buybacks. 

Showing 1 to 15 of 1,633 entries